Skip to content
Back to EOLS

Evolus, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
7
Purchases
0
Sales
7
Purchase value
$0.00
Sale value
$1.84M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

David MoatazediDirector · See Remarks
4
Filed Sep 4, 2026Period of report Sep 2, 20260001700836-26-000003
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 2, 2026
Common StockF1105,108$9.0385$950.02K499,592Direct
Filing footnotes · 1
  1. F1The shares were sold in multiple trades at prices ranging from $9.00 to $9.13. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Open on SEC EDGAR
Rui AvelarSee Remarks
4
Filed Mar 20, 2026Period of report Mar 20, 20260001570562-26-000050
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 20, 2026
Common StockF1F23,119$4.75$14.82K427,423Direct
Filing footnotes · 2
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the settlement of restricted stock unit awards.
  2. F2The shares were sold in multiple trades at prices ranging from $4.7498 to $4.7701. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open on SEC EDGAR
David MoatazediDirector · See Remarks
4Rule 10b5-1 plan disclosed
Filed Mar 20, 2026Period of report Mar 20, 20260001570562-26-000049
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 20, 2026
Common StockF1F213,669$4.7501$64.93K604,700Direct
Filing footnotes · 2
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the settlement of restricted stock unit awards.
  2. F2The shares were sold in multiple trades at prices ranging from $4.7498 to $4.775. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open on SEC EDGAR
David MoatazediDirector · See Remarks
4Rule 10b5-1 plan disclosed
Filed Mar 18, 2026Period of report Mar 16, 20260001570562-26-000046
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 17, 2026
Common StockF2F3116,720$4.8883$570.56K618,369Direct
Filing footnotes · 3
  1. F1As previously reported, on February 7, 2024, the Reporting Person was granted 134,977 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 134,977 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 67,489 shares of the Issuer's common stock. The remaining 67,488 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures.
  2. F2The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of multiple PSU and restricted stock unit awards.
  3. F3The shares were sold in multiple trades at prices ranging from $4.8874 to $5.015. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open on SEC EDGAR
Rui AvelarSee Remarks
4Rule 10b5-1 plan disclosed
Filed Mar 18, 2026Period of report Mar 16, 20260001570562-26-000045
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 17, 2026
Common StockF2F329,996$4.8883$146.63K430,542Direct
Filing footnotes · 3
  1. F1As previously reported, on February 7, 2024, the Reporting Person was granted 17,606 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 17,606 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 8,804 shares of the Issuer's common stock. The remaining 8,802 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures.
  2. F2The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of multiple PSU and restricted stock unit awards.
  3. F3The shares were sold in multiple trades at prices ranging from $4.8874 to $4.945. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open on SEC EDGAR
David MoatazediDirector · See Remarks
4Rule 10b5-1 plan disclosed
Filed Dec 29, 2025Period of report Dec 22, 20250001570562-25-000119
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 22, 2025
Common StockF110,539$7.1507$75.36K354,388Direct
Filing footnotes · 1
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
Open on SEC EDGAR
Rui AvelarSee Remarks
4Rule 10b5-1 plan disclosed
Filed Dec 29, 2025Period of report Dec 22, 20250001570562-25-000118
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 22, 2025
Common StockF12,261$7.1507$16.17K356,821Direct
Filing footnotes · 1
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.